These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10338526

  • 1. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W, Cherniak R, Casadevall A.
    Infect Immun; 1999 Jun; 67(6):3096-107. PubMed ID: 10338526
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J, Kozel TR, Casadevall A.
    J Immunol; 1998 Oct 01; 161(7):3557-68. PubMed ID: 9759877
    [Abstract] [Full Text] [Related]

  • 3. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J, Scharff MD, Casadevall A.
    Infect Immun; 1995 Sep 01; 63(9):3353-9. PubMed ID: 7642262
    [Abstract] [Full Text] [Related]

  • 4. Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
    Cleare W, Mukherjee S, Spitzer ED, Casadevall A.
    Clin Diagn Lab Immunol; 1994 Nov 01; 1(6):737-40. PubMed ID: 8556529
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
    Mukherjee J, Zuckier LS, Scharff MD, Casadevall A.
    Antimicrob Agents Chemother; 1994 Mar 01; 38(3):580-7. PubMed ID: 8203858
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J, Feldmesser M, Scharff MD, Casadevall A.
    Antimicrob Agents Chemother; 1995 Jul 01; 39(7):1398-405. PubMed ID: 7492075
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A.
    Infect Immun; 1994 Mar 01; 62(3):1079-88. PubMed ID: 8112842
    [Abstract] [Full Text] [Related]

  • 8. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M, Kress Y, Casadevall A.
    J Infect Dis; 1998 Jun 01; 177(6):1639-46. PubMed ID: 9607844
    [Abstract] [Full Text] [Related]

  • 9. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
    Feldmesser M, Casadevall A.
    J Immunol; 1997 Jan 15; 158(2):790-9. PubMed ID: 8992996
    [Abstract] [Full Text] [Related]

  • 10. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z.
    Infect Immun; 1995 Aug 15; 63(8):3005-14. PubMed ID: 7622223
    [Abstract] [Full Text] [Related]

  • 11. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.
    Nussbaum G, Anandasabapathy S, Mukherjee J, Fan M, Casadevall A, Scharff MD.
    Infect Immun; 1999 Sep 15; 67(9):4469-76. PubMed ID: 10456888
    [Abstract] [Full Text] [Related]

  • 12. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
    Beenhouwer DO, May RJ, Valadon P, Scharff MD.
    J Immunol; 2002 Dec 15; 169(12):6992-9. PubMed ID: 12471134
    [Abstract] [Full Text] [Related]

  • 13. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
    Duro RM, Netski D, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Mar 15; 10(2):252-8. PubMed ID: 12626451
    [Abstract] [Full Text] [Related]

  • 14. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR, Moussai D, Casadevall A.
    Infect Immun; 2004 Jun 15; 72(6):3674-9. PubMed ID: 15155683
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
    Brandt S, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Sep 15; 10(5):903-9. PubMed ID: 12965925
    [Abstract] [Full Text] [Related]

  • 16. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
    Casadevall A, DeShaw M, Fan M, Dromer F, Kozel TR, Pirofski LA.
    Infect Immun; 1994 Sep 15; 62(9):3864-72. PubMed ID: 8063403
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy.
    Goldman DL, Casadevall A, Zuckier LS.
    J Med Vet Mycol; 1997 Sep 15; 35(4):271-8. PubMed ID: 9292424
    [Abstract] [Full Text] [Related]

  • 18. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K, Pirofski LA.
    Infect Immun; 2004 Aug 15; 72(8):4810-8. PubMed ID: 15271943
    [Abstract] [Full Text] [Related]

  • 19. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P, Nussbaum G, Oh J, Scharff MD.
    J Immunol; 1998 Aug 15; 161(4):1829-36. PubMed ID: 9712050
    [Abstract] [Full Text] [Related]

  • 20. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D, Kozel TR.
    Infect Immun; 2002 Jun 15; 70(6):2812-9. PubMed ID: 12010967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.